Optimization of Macronutrient intake in Heart Failure
Optimization of Macronutrient intake in Heart Failure
批准号:
7750200
负责人:
William C Stanley
金额:
$28.67万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-14 至 2014-07-31
关键词:
AccelerationAcidsAddressAdverse effectsAffectApoptosisAttenuatedBloodCanis familiarisCarbohydratesCardiacCardiac MyocytesCardiolipinsCarnitineClinicalCouplingData AnalysesDeteriorationDevelopmentDietDietary SupplementationDown-RegulationEatingEnergy MetabolismEnzymesEpidemiologic StudiesFat-Restricted DietFatty AcidsFatty acid glycerol estersFibrosisFigs - dietaryFish OilsFunctional disorderGene ExpressionGenerationsGeneticGlucoseGlucose-6-PhosphateGlycemic IndexGrowthHeartHeart failureHydrogen PeroxideHypertrophyInflammationInsulinInsulin ReceptorIntakeIsoprostanesKnockout MiceLeftLeft Ventricular DysfunctionLeft Ventricular FunctionLeft Ventricular RemodelingLinoleic AcidsLinolenic AcidsMacronutrients NutritionManuscriptsMeasuresMediatingMediationMessenger RNAMetabolicMetabolismMicroarray AnalysisMitochondriaModelingMusMyocardialN-3 polyunsaturated fatty acidNADPNitric Oxide SynthaseNutritionalOilsOxidoreductasePathologyPathway interactionsPatientsPentosephosphate PathwayPhospholipidsPlasmaPolyunsaturated Fatty AcidsPreparationPreventionProductionProteinsRattusReactive Oxygen SpeciesRecommendationResearch DesignResearch PersonnelRespirationRiskRoleSamplingSaturated Fatty AcidsSignal TransductionStarchSuperoxidesTissue SampleTissuesTracerVentricularWorkadiponectindietary supplementseicosapentanoic acidfatty acid oxidationfeedinghigh standardimprovedin vivoinsulin signalingmedical schoolsmetabolic abnormality assessmentmouse modelnovelpressurepreventprogramsresponsesaturated fatsugartetrahydrobiopterin
中文摘要
目前治疗心力衰竭(HF)的药理学方法的益处接近其预期效果。
需要限制和新的治疗方法。PPG的最新结果表明,
碳水化合物/高脂肪饮食可以防止HF的发展和进展。脂肪酸
饮食组成可能对HF的发生和进展有重大影响。进气
多不饱和脂肪酸(PUFA)对心脏基因表达的影响更有利,
线粒体功能和心肌细胞凋亡。我们也
观察到高糖摄入可加速HF的发展和进展。这
项目调查了膳食常量营养素组成对
HF的进展。我们假设:1)高摄入PUFA(18:2n-6和18:3 n-3)或
EPA+DHA)预防和逆转线粒体功能,细胞凋亡,
心肌细胞肥大、纤维化、心室重塑和收缩功能障碍,
HF;和2)高糖饮食激活胰岛素刺激的生长和ROS产生,
加速了HF的发展。将在已建立的HF模型中进行研究。
通过使用以下方法在特定途径中进行靶向改变来解决不可理解的机制
营养学、药理学和遗传学方法。具体目标是:
1)评估由饱和脂肪酸或多不饱和脂肪酸组成的高脂肪饮食阻止
或与标准高碳水化合物饮食相比逆转HF的进展。
2)确定标准高碳水化合物饮食的膳食补充剂的效果
UJ-3 PUFA(EPA+DHA)对已建立的HF的进展的影响。
3)阐明胰岛素信号在HF患者高糖饮食不良反应中的作用。
4)确定ROS产生在介导高糖不良反应中的作用
HF饮食。
英文摘要
The benefits of current pharmacological approaches to treating heart failure (HF) are near their
limits and new adjunctive therapies are needed. Recent results from this PPG suggest that low
carbohydrate/high fat diets may prevent the development and progression of HF. The fatty acid
composition of the diet may have a major impact on development and progression of HF. Intake
of polyunsaturated fatty acids (PUFA) has a more favorable effect on cardiac gene expression,
mitochondrial function, and cardiomyocyte apoptosis than a high saturated fat diet. We also
observed that high sugar intake may accelerate the development and progression of HF. This
Project investigates the mechanistic effects of dietary macronutrient composition on the
progression of HF. We hypothesize that 1) high intake of PUFA (18:2n-6 and 18:3n-3) or
the EPA+DHA) prevents and reverses deterioration in mitochondrial function, apoptosis,
cardiomyocyte hypertrophy, fibrosis, chamber remodeling and contractile dysfunction in
HF; and 2) a high sugar diet activates insulin-stimulated growth and ROS production and
accelerates the progression of HF. Studies will be performed in established models of HF.
Underiying mechanisms are addressed with targeted alterations in specific pathways using
nutritional, pharmacological, and genetic approaches. The specific aims are:
1) Assess the ability of high fat diets comprised of saturated fatty acids or PUFA to stop
or reverse the progression of HF compared to a standard high carbohydrate diet.
2) Determine the effects of dietary supplementation of a standard high carbohydrate diet
with UJ-3PUFA (EPA+DHA) on the progression of established HF.
3) Elucidate the role of insulin signaling in the adverse effects of a high sugar diet in HF.
4) Determine the role of ROS generation in mediating the adverse effects of high sugar
diet in HF.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial Proteome Dynamics in Heart Failure Assessed with Heavy Water
-
批准号:8401772
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2012
-
负责人:William C Stanley
-
依托单位:
Docosahexaenoic Acid, Mitochondrial Dysfunction and Cardiac Reperfusion Injury
-
批准号:8205687
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2011
-
负责人:William C Stanley
-
依托单位:
Docosahexaenoic Acid, Mitochondrial Dysfunction and Cardiac Reperfusion Injury
-
批准号:8319356
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2011
-
负责人:William C Stanley
-
依托单位:
Administration
-
批准号:7750207
-
项目类别:
-
资助金额:$28.67万
-
财政年份:2009
-
负责人:William C Stanley
-
依托单位:
Metabolism
-
批准号:7750209
-
项目类别:
-
资助金额:$28.67万
-
财政年份:2009
-
负责人:William C Stanley
-
依托单位:
Metabolic Signaling in the Cardiovascular System
-
批准号:7540168
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2008
-
负责人:William C Stanley
-
依托单位:
Omega-3 Fatty Acids and Heart Failure
-
批准号:7471865
-
项目类别:
-
资助金额:$28.13万
-
财政年份:2008
-
负责人:William C Stanley
-
依托单位:
Omega-3 Fatty Acids and Heart Failure
-
批准号:7615631
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2008
-
负责人:William C Stanley
-
依托单位:
Cardiac Energy Metabolism in Heart Failure
-
批准号:7329172
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2006
-
负责人:William C Stanley
-
依托单位:
Cardiac Energy Metabolism in Heart Failure
-
批准号:7070291
-
项目类别:
-
资助金额:$3.94万
-
财政年份:2006
-
负责人:William C Stanley
-
依托单位:
Cardiac Energy Metabolism in Heart Failure
-
批准号:7643580
-
项目类别:
-
资助金额:$3.87万
-
财政年份:2006
-
负责人:William C Stanley
-
依托单位:
CARDIAC ENERGY METABOLISM IN HEART FAILURE
-
批准号:7058898
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:William C Stanley
-
依托单位:
Core A-- Administrative Core
-
批准号:7000640
-
项目类别:
-
资助金额:$25.22万
-
财政年份:2004
-
负责人:William C Stanley
-
依托单位:
Metabolic Regulation in Heart Failure
-
批准号:7000629
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2004
-
负责人:William C Stanley
-
依托单位:
Core C-- Metabolism Core
-
批准号:7001157
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2004
-
负责人:William C Stanley
-
依托单位:
Cardiac Energy Metabolism in Heart Failure
-
批准号:8127901
-
项目类别:
-
资助金额:$223.08万
-
财政年份:2003
-
负责人:William C Stanley
-
依托单位:
Cardiac Energy Metabolism in Heart Failure
-
批准号:7428750
-
项目类别:
-
资助金额:$178.9万
-
财政年份:2003
-
负责人:William C Stanley
-
依托单位:
Cardiac Energy Metabolism in Heart Failure
-
批准号:6677163
-
项目类别:
-
资助金额:$170.72万
-
财政年份:2003
-
负责人:William C Stanley
-
依托单位:
Cardiac Energy Metabolism in Heart Failure
-
批准号:6772597
-
项目类别:
-
资助金额:$173.48万
-
财政年份:2003
-
负责人:William C Stanley
-
依托单位:
Cardiac Energy Metabolism in Heart Failure
-
批准号:7099673
-
项目类别:
-
资助金额:$179.15万
-
财政年份:2003
-
负责人:William C Stanley
-
依托单位:
国内基金
海外基金
登录
查看更多内容
具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
-
批准号:22007039
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:王黎明
-
依托单位:
海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2019
-
负责人:朱义广
-
依托单位:
手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
-
批准号:21372217
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:袁伟成
-
依托单位:
对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
-
批准号:21172061
-
项目类别:面上项目
-
资助金额:30.0万元
-
批准年份:2011
-
负责人:许新华
-
依托单位:
钛及含钛Lewis acids促臭氧/过氧化氢体系氧化性能的广普性、高效性及其机制
-
批准号:21176225
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:童少平
-
依托单位:
基于Zip Nucleic Acids引物对高度降解和低拷贝DNA检材的STR分型研究
-
批准号:81072511
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2010
-
负责人:严江伟
-
依托单位:
海洋天然产物Makaluvic acids 的全合成及其对南海鱼虱存活的影响
-
批准号:30660215
-
项目类别:地区科学基金项目
-
资助金额:21.0万元
-
批准年份:2006
-
负责人:王世范
-
依托单位: